Takeda Pharmaceutical Co.'s net profit under IFRS for 6 months of 2020 fiscal year was ¥86.589 billion, up 15.7% from ¥74.834 billion the previous year. Revenue decreased by 4.2% to ¥1.591 trillion against ¥1.66 trillion the year before.